Skip to content

Study of Placental Inflammation in Gestational Diabetes

Study of Placental Inflammation in Gestational Diabetes: the Role of the Inflammosome NLRP3 and the Scavenger Receptor of Inflammatory Chemokines D6

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06884696
Enrollment
40
Registered
2025-03-19
Start date
2022-07-01
Completion date
2025-06-30
Last updated
2025-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus (GDM)

Brief summary

The aim of this study is to investigate the placental inflammation in women with gestational diabetes mellitus, in particular the role of inflammasome NLRP3 and the chemokine scavenger decoy receptor D6

Detailed description

The aim of this study is to investigate systemic and placental inflammation in women with gestational diabetes mellitus, in particular the role of inflammasome NLRP3 and the chemokine scavenger decoy receptor D6, compared to women with uncomplicated pregnancy

Interventions

Placental sampling after caesarean section

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Women with gestational diabetes mellitus * Women with uncomplicated pregnancy * Age \>18 years * Singleton pregnancy

Exclusion criteria

* Age \< 18 years * Infections (HIV,HCV) * Multiple pregnancy * Cancer

Design outcomes

Primary

MeasureTime frameDescription
Placental inflammationAt delivery/birthAnalysis of protein expression of inflammasome NLRP3 and D6 scavenger receptor in placental tissue.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026